Success examples
The lung microvasculature promotes alveolar type 2 cell differentiation via secreted SPARCL1

Panza P., Kim H-T., Lautenschläger T., Piesker J., Günther S., Alayoubi Y., Cleaver O., Looso M., Stainier D. Y. R.

Stem Cell Reports. 2025, 102451. Online ahead of print.

IKKβ inhibitor
DOI
PubMed
Success examples
Spatio-temporal control of mitosis using light via a Plk1 inhibitor caged for activity and cellular permeability

von Glasenapp V., Almeida A. C., Chang D., Gasic I., Winssinger N., Gotta M.

Nat Commun. 2025, 16(1):1599.

PLK1 inhibitor
DOI
PubMed
Success examples
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer

Ekstrom T. L., Rosok R. M., Abdelrahman A. M., Parassiadis C., Manjunath M., Dittrich M. Y., Wang X., Kutschat A. P., Kanakan A., Rajput A., Schacherer N., Lukic T., Carlson D. M., Thiel J., Kopp W., Stroebel P., Ellenrieder V., Gaedcke J., Dong M., Najafova Z., Truty M. J., Hessmann E., Johnsen S. A. 

Gut 2025, gutjnl-2024-334374. Online ahead of print.

Glucocorticoid Receptor (GR) Agonist
DOI
PubMed
Success examples
Identification of 5-amino-1,3,4-thiadiazole appended isatins as bioactive small molecules with polypharmacological activities

Azam U., Humayun W. A., Avathan Veettil A. K., Liu Y., Hastürk O., Jiang M., Sievers S., Wu P., Naseer M. M.

RSC Med. Chem. 2025.

CCR10 antagonist
DOI
Success examples
Characterization of a pleomorphic rhabdomyosarcoma cell line

Stickler S., Lang C., Rieche M., Eggerstorfer M-T., Hohenegger M., Hochmair M., Hamilton G.

Sci Rep. 2025, 15(1):2893.

GSK-3 inhibitor
DOI
PubMed
Success examples
A stromal inflammasome Ras safeguard against Myc-driven lymphomagenesis

Kent A., Yee Mon K. J., Hutchins Z., Putzel G., Zhigarev D., Grier A., Jia B., Kortlever R. M., Barbet G., Evan G. I., Blander J. M.

Nat Immunol. 2025, 26(1):53-67.

KRAS switch I/II pocket inhibitor
DOI
PubMed